↑PDB3N7S; ter Haar E, Koth CM, Abdul-Manan N, Swenson L, Coll JT, Lippke JA, Lepre CA, Garcia-Guzman M, Moore JM (September 2010). „Crystal structure of the ectodomain complex of the CGRP receptor, a class-B GPCR, reveals the site of drug antagonism”. Structure18 (9): 1083–93. DOI:10.1016/j.str.2010.05.014. PMID20826335.
↑Aiyar N, Rand K, Elshourbagy NA, Zeng Z, Adamou JE, Bergsma DJ, Li Y (May 1996). „A cDNA encoding the calcitonin gene-related peptide type 1 receptor”. J. Biol. Chem.271 (19): 11325–9. DOI:10.1074/jbc.271.19.11325. PMID8626685.
↑McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, Solari R, Lee MG, Foord SM (May 1998). „RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor”. Nature393 (6683): 333–9. DOI:10.1038/30666. PMID9620797.
↑Kamitani S, Asakawa M, Shimekake Y, Kuwasako K, Nakahara K, Sakata T (April 1999). „The RAMP2/CRLR complex is a functional adrenomedullin receptor in human endothelial and vascular smooth muscle cells”. FEBS Lett.448 (1): 111–4. DOI:10.1016/S0014-5793(99)00358-0. PMID10217420.
↑„Receptor properties”. SenseLab Project: Membrane properties resource. Yale University. Arhivirano iz originala na datum 2009-02-28. Pristupljeno 28. 09. 2008.
Literatura
Born W, Muff R, Fischer JA (2002). „Functional interaction of G protein-coupled receptors of the adrenomedullin peptide family with accessory receptor-activity-modifying proteins (RAMP).”. Microsc. Res. Tech.57 (1): 14–22. DOI:10.1002/jemt.10051. PMID11921352.
Yallampalli C, Chauhan M, Thota CS, et al. (2003). „Calcitonin gene-related peptide in pregnancy and its emerging receptor heterogeneity.”. Trends Endocrinol. Metab.13 (6): 263–9. PMID12128288.
Foord SM, Craig RK (1988). „Isolation and characterisation of a human calcitonin-gene-related-peptide receptor.”. Eur. J. Biochem.170 (1-2): 373–9. DOI:10.1111/j.1432-1033.1987.tb13710.x. PMID2826160.
Skofitsch G, Jacobowitz DM (1986). „Autoradiographic distribution of 125I calcitonin gene-related peptide binding sites in the rat central nervous system.”. Peptides6 (5): 975–86. DOI:10.1016/0196-9781(85)90331-6. PMID3001670.
Flühmann B, Muff R, Hunziker W, et al. (1995). „A human orphan calcitonin receptor-like structure.”. Biochem. Biophys. Res. Commun.206 (1): 341–7. DOI:10.1006/bbrc.1995.1047. PMID7818539.
Aiyar N, Rand K, Elshourbagy NA, et al. (1996). „A cDNA encoding the calcitonin gene-related peptide type 1 receptor.”. J. Biol. Chem.271 (19): 11325–9. DOI:10.1074/jbc.271.19.11325. PMID8626685.
McLatchie LM, Fraser NJ, Main MJ, et al. (1998). „RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor.”. Nature393 (6683): 333–9. DOI:10.1038/30666. PMID9620797.
Sams A, Jansen-Olesen I (1999). „Expression of calcitonin receptor-like receptor and receptor-activity-modifying proteins in human cranial arteries.”. Neurosci. Lett.258 (1): 41–4. DOI:10.1016/S0304-3940(98)00844-1. PMID9876047.
Kamitani S, Asakawa M, Shimekake Y, et al. (1999). „The RAMP2/CRLR complex is a functional adrenomedullin receptor in human endothelial and vascular smooth muscle cells.”. FEBS Lett.448 (1): 111–4. DOI:10.1016/S0014-5793(99)00358-0. PMID10217420.
Frayon S, Cueille C, Gnidéhou S, et al. (2000). „Dexamethasone increases RAMP1 and CRLR mRNA expressions in human vascular smooth muscle cells.”. Biochem. Biophys. Res. Commun.270 (3): 1063–7. DOI:10.1006/bbrc.2000.2552. PMID10772950.
Kuwasako K, Shimekake Y, Masuda M, et al. (2000). „Visualization of the calcitonin receptor-like receptor and its receptor activity-modifying proteins during internalization and recycling.”. J. Biol. Chem.275 (38): 29602–9. DOI:10.1074/jbc.M004534200. PMID10882736.
Evans BN, Rosenblatt MI, Mnayer LO, et al. (2000). „CGRP-RCP, a novel protein required for signal transduction at calcitonin gene-related peptide and adrenomedullin receptors.”. J. Biol. Chem.275 (40): 31438–43. DOI:10.1074/jbc.M005604200. PMID10903324.
Hilairet S, Foord SM, Marshall FH, Bouvier M (2001). „Protein-protein interaction and not glycosylation determines the binding selectivity of heterodimers between the calcitonin receptor-like receptor and the receptor activity-modifying proteins.”. J. Biol. Chem.276 (31): 29575–81. DOI:10.1074/jbc.M102722200. PMID11387328.
Kamitani S, Sakata T (2001). „Glycosylation of human CRLR at Asn123 is required for ligand binding and signaling.”. Biochim. Biophys. Acta1539 (1-2): 131–9. DOI:10.1016/S0167-4889(01)00100-8. PMID11389975.
Nikitenko LL, Brown NS, Smith DM, et al. (2001). „Differential and cell-specific expression of calcitonin receptor-like receptor and receptor activity modifying proteins in the human uterus.”. Mol. Hum. Reprod.7 (7): 655–64. DOI:10.1093/molehr/7.7.655. PMID11420389.
Hilairet S, Bélanger C, Bertrand J, et al. (2001). „Agonist-promoted internalization of a ternary complex between calcitonin receptor-like receptor, receptor activity-modifying protein 1 (RAMP1), and beta-arrestin.”. J. Biol. Chem.276 (45): 42182–90. DOI:10.1074/jbc.M107323200. PMID11535606.
Aiyar N, Disa J, Pullen M, Nambi P (2002). „Receptor activity modifying proteins interaction with human and porcine calcitonin receptor-like receptor (CRLR) in HEK-293 cells.”. Mol. Cell. Biochem.224 (1-2): 123–33. DOI:10.1023/A:1011907328682. PMID11693189.
Hagner S, Haberberger RV, Overkamp D, et al. (2002). „Expression and distribution of calcitonin receptor-like receptor in human hairy skin.”. Peptides23 (1): 109–16. DOI:10.1016/S0196-9781(01)00586-1. PMID11814625.
Vanjske veze
„Calcitonin receptors: CALCRL”. IUPHAR Database of Receptors and Ion Channels. International Union of Basic and Clinical Pharmacology.